Concepedia

Stig Boström

SB

Statistics

Publications

9

Citations

273

H-Index

9

Active since

1978

Affiliations

AstraZeneca (Sweden)(Current)

AstraZeneca (United States)

Barmherzige Schwestern Krankenhaus Wien

University of Vienna

Stig Boström is an author at AstraZeneca (Sweden) specializing in hemostasis, thrombin generation, and medicine.

Publications per year

1978–2004

9

Publications

9

Effect of recombinant factor VIIa on melagatran-induced inhibition of thrombin generation and platelet activation in healthy volunteers

Marcel Levi, Troy C. Sarich, Stig Boström et al. · Thrombosis and Haemostasis · 2004 · 94 citations

Medicine, Hematology, Pharmacology +17

DETERMINATION OF THE KINETIC CONSTANTS OF TISSUE FACTOR/FACTOR VII/FACTOR VIIA AND ANTITHROMBIN/HEPARIN USING SURFACE PLASMON RESONANCE

Petter Björquist, Stig Boström · Thrombosis Research · 1997 · 36 citations

Medicine, Biochemistry, Hematology +10

Low molecular weight enzymatic fish protein hydrolysates: chemical composition and nutritive value

Georgios Lalasidis, Stig Boström, Lars Börje Sjöberg · Journal of Agricultural and Food Chemistry · 1978 · 35 citations

Agriculture, Food Science, Nutritional Sciences +9

Effects of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran, and dalteparin on the endogenous thrombin potential in venous blood from healthy male subjects

Stig Boström, Göran FH Hansson, Troy C. Sarich · Blood Coagulation & Fibrinolysis · 2003 · 31 citations

Medicine, Hematology, Pharmacology +17

Reduced glucose incorporation to triglycerides following chronic exposure of human fat cells to growth hormone

Gudrun Nyberg, Stig Boström, Rolf Johansson et al. · European Journal of Endocrinology · 1980 · 18 citations

Life Sciences, Biochemistry, Physiology +17

1–5 of 9